Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
Clinical trial NCT07639086 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07639086
- Sponsor
- Virginia Commonwealth University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2030-03-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.